TALARIS THERAPEUTICS INC's ticker is TALS and the CUSIP is 87410C104. A total of 54 filers reported holding TALARIS THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $10,000 | +400.0% | 3,440 | +166.9% | 0.00% | – |
| Q1 2023 | $2,000 | -50.0% | 1,289 | -64.3% | 0.00% | – |
| Q4 2022 | $4,000 | +300.0% | 3,609 | +1184.3% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 281 | +123.0% | 0.00% | – |
| Q2 2022 | $1,000 | -92.3% | 126 | -90.4% | 0.00% | – |
| Q1 2022 | $13,000 | -81.9% | 1,310 | -71.9% | 0.00% | – |
| Q4 2021 | $72,000 | +500.0% | 4,669 | +400.4% | 0.00% | – |
| Q3 2021 | $12,000 | +33.3% | 933 | +53.2% | 0.00% | – |
| Q2 2021 | $9,000 | – | 609 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Qiming U.S. Ventures Management, LLC | 2,932,606 | $5,513,299 | 6.67% |
| BML Capital Management, LLC | 1,929,484 | $3,627,430 | 3.14% |
| Western Standard LLC | 586,481 | $1,102,584 | 1.12% |
| Cormorant Asset Management, LP | 900,649 | $1,693 | 0.11% |
| Artal Group S.A. | 914,262 | $1,719 | 0.10% |
| Values First Advisors, Inc. | 52,896 | $99,445 | 0.06% |
| Blackstone Inc. | 8,089,315 | $15,207,912 | 0.06% |
| Eventide Asset Management | 1,561,092 | $2,934,853 | 0.05% |
| Marquette Asset Management, LLC | 101,375 | $190,585 | 0.05% |
| VIKING GLOBAL INVESTORS LP | 3,289,617 | $6,184,480 | 0.03% |